ContributorsPublishersAdvertisers

Common Mutations in Chinese Patients With NSCLC Linked With Treatment Outcomes, Disease Severity

ajmc.com
 2022-01-20

Cover picture for the articleThe frequency of several mutations that inhibit response to tyrosine kinase inhibitors and tend to lead to increased disease severity was elevated in Chinese patients with non-small cell lung cancer. Chinese patients with non-small cell lung cancer (NSCLC) exhibited increased frequency of several mutations that may affect the efficacy...

www.ajmc.com

Comments / 0

Comments / 0